Hypertension (high blood pressure) Board decisions

The Board remands the claims for service connection for a cardiovascular disease other than hypertension and asthma due to insufficient evidence.

The Board remands the Veteran's claims for additional development, specifically to obtain an adequate VA medical opinion that addresses the etiology of the Veteran's claimed conditions, with consideration and discussion of relevant evidence.

The Board is remanding the Veteran's claims for service connection for hypertension and Type II diabetes mellitus to correct a pre-decisional duty to assist error.

The appeal seeking an initial compensable rating for hypertension was dismissed due to a prohibited concurrent election of review options.

The Board granted an effective date of March 22, 2019, for the awards of service connection for arteriosclerotic heart disease (CAD), prostate cancer, and hypertension.

The Board remands the claims for service connection for primary cutaneous B-Cell lymphoma, Non-Hodgkin's disease and other conditions to correct a pre-decisional duty-to-assist error.

The Board granted service connection for hypertension, residuals of stroke, and osteoarthritis right hip including right thigh injury. The Veteran's disability rating in excess of 40 percent for osteoarthritis and degenerative disc disease of lumbar spine was denied.

The Board restored the Veteran's 70 percent rating for insomnia disorder, effective April 1, 2024. The appeal to establish service connection for various conditions was denied or dismissed.

The Board remands the case to schedule a VA medical opinion to determine if the Veteran's cause of death is etiologically related to chemical exposure during service.

The Board denied the veteran's claims for earlier effective dates and higher ratings, finding that the statutory requirements were not met.

The Board denied increased ratings for seborrheic dermatitis, diabetes mellitus II, left and right upper extremity peripheral neuropathy, and right lower extremity peripheral neuropathy. However, it granted an initial 40 percent rating for both the right and left lower extremity peripheral neuropathy, as well as a 10 percent rating for hypertension.

The Veteran's service connection for erectile dysfunction (ED) was granted, while his claim for high blood pressure was denied. The remaining claims were remanded.

The Board dismissed all claims for higher initial ratings and service connection, as the Veteran requested a higher-level review of these issues in May 2024 but then appealed to the Board in August 2024, leading to concurrent review which is not allowed.

The Board denied the veteran's requests for extensions of time to file appeals regarding service connection for hypertension and seborrheic dermatitis, dismissing the attempted appeals.

The Board denied service connection for multiple conditions, including high cholesterol, hypertension, and various musculoskeletal issues, as well as a compensable rating for acne vulgaris and migraine.

The Board denied the Veteran's claims for a compensable rating for hypertension and a separate rating for right knee instability, and dismissed his claim for TDIU as moot.

The Board granted service connection for the Veteran's cause of death, which was determined to be substantially or materially contributed to by diabetes mellitus, type II and hypertension, both caused by obesity resulting from a service-connected disability.

The Board denied a rating higher than 10 percent for hypertension and granted restoration of a 20 percent rating for lumbosacral strain effective March 6, 2020.

The Board remands the claims for service connection and initial rating due to the need for additional VA examinations.

The Board denied the Veteran's claim for a compensable rating for service-connected hypertension as the evidence did not show that his condition met the criteria for a 10 percent rating.